Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
Morrow DA, Alberts MJ, Mohr JP, Ameriso SF, Bonaca MP, Goto S, Hankey GJ, Murphy SA, Scirica BM, Braunwald E; Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events–TIMI 50 Steering Committee and Investigators.
Morrow DA, et al. Among authors: alberts mj.
Stroke. 2013 Mar;44(3):691-8. doi: 10.1161/STROKEAHA.111.000433. Epub 2013 Feb 8.
Stroke. 2013.
PMID: 23396280
Clinical Trial.